Login / Signup

Real-World Effectiveness of Newly Initiated Systemic Therapy for Atopic Dermatitis in the United States: A Claims Database Analysis.

Jashin J WuMarie-Hélène LafeuilleBruno EmondIman FakihMei Sheng DuhJoseph Christopher CappelleriNatalie YinClaire FeeneyDaniela E MyersMarco daCosta DiBonaventura
Published in: Advances in therapy (2022)
Non-response was common in patients with AD who required systemic treatment, and non-response indicators occurred significantly more frequently with SIS treatment than with dupilumab treatment.
Keyphrases
  • atopic dermatitis
  • randomized controlled trial
  • systematic review
  • emergency department
  • health insurance
  • replacement therapy
  • electronic health record
  • adverse drug